Ad
related to: regeneron covid antibody treatment
Search results
Regeneron (REGN) Q4 Earnings & Sales Beat, Eylea Sales Decline
Zacks via Yahoo Finance· 1 year agoRegeneron Pharmaceuticals, Inc. REGN delivered better-than-expected fourth-quarter 2022 results even...
Will Loss of REGEN-COV Sales Hurt Regeneron (REGN) in 2022?
Zacks via Yahoo Finance· 2 years agoBiotech giant Regeneron Pharmaceuticals REGN witnessed a massive surge in sales in 2021, driven by...
Regeneron (REGN) Down 2.3% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 2 years agoA month has gone by since the last earnings report for Regeneron (REGN). Shares have lost about 2.3%...
Should You Sell This Stock Following a Regulatory Roadblock?
Motley Fool via Yahoo Finance· 2 months agoBiotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) has been on fire over the past three years....
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Zacks via Yahoo Finance· 1 month agoRegeneron Pharmaceuticals, Inc. REGN delivered lower-than-expected first-quarter 2024 results due to...
This Recent FDA Approval Could Give Regeneron's Top Line a Big Boost
Motley Fool· 9 months agoRegeneron Pharmaceuticals (NASDAQ: REGN) has made for a fantastic growth story over the years. From...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 month agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron...
Regeneron Soars As Eylea Outplays Competition, Both Beating Forecasts And Growing
Investor's Business Daily· 2 years agoRegeneron Pharmaceuticals outplayed its competition in eye diseases Wednesday, reporting Eylea sales...
If You Invested $1000 in Regeneron 10 Years Ago, This Is How Much You'd Have Now
Zacks via Yahoo Finance· 2 years agoFor most investors, how much a stock's price changes over time is important. This factor can impact...
Regeneron Sinks Despite Massive Earnings Beat On A Notable Blockbuster Miss
Investor's Business Daily· 2 years agoRegeneron Pharmaceuticals handily beat Wall Street's third-quarter earnings estimate Thursday, but...
